Abstract | OBJECTIVES: METHODS: C57BL/6 mice (male, 10 weeks of age) were fed a high-fat and high- sucrose (HFHS) diet to induce NAFLD. Major Cyp subtype mRNA expression in the liver was measured by real-time RT-PCR. KEY FINDINGS: Body and liver weights at 4 and 12 weeks were significantly higher in mice fed the HFHS diet compared with control. The HFHS diet significantly increased the accumulation of cholesterol and triglycerides at 12 weeks. Under this condition, the HFHS diet increased the expression of Cyp1a2 and decreased that of Cyp3a11 at 1 week and thereafter. On the other hand, Cyp1a1, 2b10 and 2c29 mRNA expression levels in the liver were significantly increased at 12 weeks only. Resveratrol (0.05% (w/w) in diet) slightly suppressed lipid accumulation in the liver, but failed to recover impaired Cyp gene expression levels in NAFLD. CONCLUSIONS: Drug metabolism may be impaired in NAFLD, and each Cyp subtype is regulated in a different manner.
|
Authors | Tsuyoshi Chiba, Keiko Noji, Shohei Shinozaki, Sachina Suzuki, Keizo Umegaki, Kentaro Shimokado |
Journal | The Journal of pharmacy and pharmacology
(J Pharm Pharmacol)
Vol. 68
Issue 12
Pg. 1567-1576
(Dec 2016)
ISSN: 2042-7158 [Electronic] England |
PMID | 27757967
(Publication Type: Journal Article)
|
Copyright | © 2016 Royal Pharmaceutical Society. |
Chemical References |
- Dietary Sucrose
- Isoenzymes
- Lipids
- RNA, Messenger
- Stilbenes
- Cytochrome P-450 Enzyme System
- Resveratrol
|
Topics |
- Animals
- Cytochrome P-450 Enzyme System
(genetics, metabolism)
- Diet, High-Fat
- Dietary Sucrose
- Disease Models, Animal
- Gene Expression Regulation, Enzymologic
- Isoenzymes
- Lipids
(blood)
- Liver
(drug effects, enzymology, pathology)
- Male
- Mice, Inbred C57BL
- Non-alcoholic Fatty Liver Disease
(blood, enzymology, genetics, pathology)
- RNA, Messenger
(genetics, metabolism)
- Resveratrol
- Stilbenes
(pharmacology)
- Time Factors
|